Audizen Drops’ official launch introduces a thoughtfully crafted supplement for sciatic nerve discomfort and neuropathy. By ...

Six weeks is a long time to sit in the unknown, but that’s how long I waited to find out if the 11mm tumour growing in my ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Cancer is no longer just a disease of ...

Experts see tolebrutinib as part of a broader shift toward treatments that target the neurodegeneration in MS, not just its ...

Brain's immune cells, microglia, are constantly renewed. New research reveals a key gene, pu.1, partners with the "guardian ...

The European Commission (EC) has granted conditional approval to SpringWorks Therapeutics’ Ezmekly (mirdametinib) to treat ...

Plexiform neurofibromas can transform into malignant peripheral nerve sheath tumors, an aggressive and potentially fatal disease. 5 Surgical removal can be challenging due to the infiltrative ...

Mirdametinib is marketed under the brand name EZMEKLY® in the European Union and is conditionally approved by the European ...

Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST) ...

BackgroundMalignant peripheral nerve sheath tumors (MPNST) are a severe complication of neurofibromatosis type 1 (NF1). The median age at diagnosis is 47.1 y ...

RegeNerve6 officially launches as a comprehensive nerve health supplement targeting neuropathy relief, peripheral neuropathy symptoms, and nerve pain management. This science-backed formula ...